Geode Capital Management, LLC Albireo Pharma, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$18.01 - $23.78 $368,610 - $486,705	20,467 Added 6.54%	333,211 $7.2 Million
Q3 2022 Nov 14, 2022	SELL	$16.32 - $26.37 $260,418 - $420,786	-15,957 Reduced 4.85%	312,744 $6.05 Million
Q2 2022 Aug 12, 2022	SELL	$18.54 - $37.29 $163,003 - $327,853	-8,792 Reduced 2.61%	328,701 $6.53 Million
Q1 2022 May 13, 2022	BUY	$23.94 - $33.74 $938,471 - $1.32 Million	39,201 Added 13.14%	337,493 $10.1 Million
Q4 2021 Feb 11, 2022	BUY	$21.19 - $31.29 $37,548 - $55,445	1,772 Added 0.6%	298,292 $6.95 Million
Q3 2021 Nov 12, 2021	BUY	$27.36 - $35.98 $193,188 - $254,054	7,061 Added 2.44%	296,520 $9.25 Million
Q2 2021 Aug 13, 2021	BUY	$28.9 - $36.87 $100,600 - $128,344	3,481 Added 1.22%	289,459 $10.2 Million
Q1 2021 May 12, 2021	BUY	$32.03 - $42.85 $896,936 - $1.2 Million	28,003 Added 10.85%	285,978 $10.1 Million
Q4 2020 Feb 12, 2021	BUY	$31.56 - $42.16 $1.03 Million - $1.38 Million	32,794 Added 14.56%	257,975 $9.68 Million
Q3 2020 Nov 13, 2020	BUY	$23.19 - $41.61 $815,128 - $1.46 Million	35,150 Added 18.5%	225,181 $7.51 Million
Q2 2020 Aug 13, 2020	BUY	$14.82 - $29.92 $114,780 - $231,730	7,745 Added 4.25%	190,031 $5.03 Million
Q1 2020 May 14, 2020	BUY	$11.67 - $27.23 $467,651 - $1.09 Million	40,073 Added 28.18%	182,286 $2.98 Million
Q4 2019 Feb 13, 2020	BUY	$16.92 - $28.96 $149,149 - $255,282	8,815 Added 6.61%	142,213 $3.62 Million
Q3 2019 Nov 12, 2019	BUY	$20.0 - $31.88 $134,380 - $214,201	6,719 Added 5.3%	133,398 $2.67 Million
Q2 2019 Aug 14, 2019	BUY	$30.67 - $37.86 $550,925 - $680,079	17,963 Added 16.52%	126,679 $4.08 Million
Q1 2019 May 14, 2019	BUY	$22.22 - $32.21 $250,686 - $363,393	11,282 Added 11.58%	108,716 $3.5 Million
Q4 2018 Feb 13, 2019	BUY	$20.9 - $32.57 $207,369 - $323,159	9,922 Added 11.34%	97,434 $2.39 Million
Q3 2018 Nov 13, 2018	BUY	$29.29 - $36.87 $182,066 - $229,183	6,216 Added 7.65%	87,512 $2.88 Million
Q2 2018 Aug 14, 2018	BUY	$28.9 - $37.31 $969,884 - $1.25 Million	33,560 Added 70.3%	81,296 $2.89 Million
Q1 2018 May 15, 2018	BUY	$26.78 - $39.35 $425,373 - $625,035	15,884 Added 49.87%	47,736 $1.55 Million
Q3 2017 Nov 14, 2017	BUY	$20.44 - $25.65 $108,393 - $136,021	5,303 Added 19.97%	31,852 $667,000
Q2 2017 Aug 14, 2017	BUY	N/A	26,549	26,549 $546,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account